| Medical and Health Sciences | Lifetime | 41 | US 21 | 100.00 |
| Medical and Health Sciences | 2021-2025 | 358 | US 127 | 99.93 |
| Hematology | Lifetime | 2 | US 2 | 99.98 |
| Medical Genetics | Lifetime | 4 | US 3 | 99.96 |
| Public, Environmental and Occupational Health | Lifetime | 207 | US 105 | 99.70 |
| Rheumatology | Lifetime | 59 | US 24 | 99.73 |
| Oncology | Lifetime | 420 | US 240 | 99.27 |
| Pathology and Forensic Medicine | Lifetime | 470 | US 222 | 98.01 |
| Hematology | 2021-2025 | 11 | US 7 | 99.77 |
| Medical Genetics | 2021-2025 | 34 | US 17 | 99.26 |
| Oncology | 2021-2025 | 355 | US 151 | 96.27 |
| Public, Environmental and Occupational Health | 2021-2025 | 459 | US 177 | 95.73 |
| Econometrics and Quantitative Economics | 2021-2025 | 993 | US 297 | 93.29 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 2 | US 2 | 99.99 |
| Acute Myeloid Leukemia Research | Lifetime | 2 | US 2 | 99.98 |
| Acute Lymphoblastic Leukemia research | Lifetime | 2 | US 2 | 99.97 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 2 | US 2 | 99.99 |
| Eosinophilic Disorders and Syndromes | Lifetime | 2 | US 2 | 99.98 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 3 | US 3 | 99.94 |
| Histone Deacetylase Inhibitors Research | Lifetime | 15 | US 13 | 99.76 |
| Lymphoma Diagnosis and Treatment | Lifetime | 73 | US 35 | 99.74 |
| Neutropenia and Cancer Infections | Lifetime | 21 | US 15 | 99.63 |
| Multiple Myeloma Research and Treatments | Lifetime | 41 | US 24 | 99.72 |
| Retinoids in leukemia and cellular processes | Lifetime | 64 | US 39 | 99.13 |
| HER2/EGFR in Cancer Research | Lifetime | 153 | US 76 | 99.25 |
| Protein Degradation and Inhibitors | Lifetime | 109 | US 65 | 99.01 |
| Hedgehog Signaling Pathway Studies | Lifetime | 100 | US 62 | 98.13 |
| Cancer Treatment and Pharmacology | Lifetime | 408 | US 218 | 98.81 |
| Hematopoietic Stem Cell Transplantation | Lifetime | 401 | US 219 | 98.38 |
| Click Chemistry and Applications | Lifetime | 409 | US 141 | 97.33 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 152 | US 86 | 96.42 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 742 | US 309 | 97.19 |
| Cancer therapeutics and mechanisms | Lifetime | 750 | US 381 | 96.45 |
| Hematological disorders and diagnostics | Lifetime | 371 | US 179 | 94.99 |
| Tumors and Oncological Cases | Lifetime | 505 | US 277 | 95.56 |
| Chemotherapy-related skin toxicity | Lifetime | 167 | US 91 | 94.34 |
| Kruppel-like factors research | Lifetime | 335 | US 128 | 93.90 |
| Economic and Financial Impacts of Cancer | Lifetime | 621 | US 392 | 94.18 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 901 | US 481 | 93.82 |
| Mast cells and histamine | Lifetime | 763 | US 259 | 93.84 |
| Vascular Tumors and Angiosarcomas | Lifetime | 523 | US 260 | 94.06 |
| Fungal Plant Pathogen Control | Lifetime | 798 | US 193 | 89.48 |
| Chromatin Remodeling and Cancer | Lifetime | 603 | US 277 | 87.75 |
| Drug-Induced Ocular Toxicity | Lifetime | 339 | US 161 | 82.35 |
| Gestational Trophoblastic Disease Studies | Lifetime | 830 | US 295 | 80.82 |
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 823 | US 287 | 62.34 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 17 | US 9 | 99.66 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 11 | US 10 | 99.76 |
| Acute Myeloid Leukemia Research | 2021-2025 | 35 | US 26 | 99.62 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 29 | US 23 | 99.37 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 14 | US 11 | 99.24 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 46 | US 31 | 98.86 |
| HER2/EGFR in Cancer Research | 2021-2025 | 172 | US 61 | 97.40 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 142 | US 89 | 95.13 |
| Click Chemistry and Applications | 2021-2025 | 235 | US 20 | 92.03 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 458 | US 217 | 93.97 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 212 | US 72 | 87.44 |
| Global Cancer Incidence and Screening | 2021-2025 | 866 | US 372 | 88.63 |
| Histone Deacetylase Inhibitors Research | 2021-2025 | 722 | US 204 | 78.06 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 477 | US 172 | 76.99 |
| Quinazolinone synthesis and applications | 2021-2025 | 511 | US 26 | 66.05 |
| Synthesis of Tetrazole Derivatives | 2021-2025 | 342 | US 14 | 36.64 |
